NEW YORK, Sept. 20 – MediChem Life Sciences said Thursday it has cut 25 percent of its workforce and will reduce other operating expenses in a restructuring plan designed to save the company $5.5 million in 2002. 

The staff reductions “affected all functional areas in the company,” Richard Wieland, executive vice president and chief financial officer of MediChem, told GenomeWeb. The most significant reductions were associated with the consolidation of MediChem’s laboratory operations in the Chicago area. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.